Aashka Hospitals (BSE 543346)₹95.80−0.21%Hospital
In the Mar 2026 quarter (standalone), Aashka Hospitals reported sales of ₹12.62 Cr, up 22.2% from Mar 2025, and net profit of ₹2.55 Cr, up 53.6% year on year. For the year to Mar 2026, sales were ₹23.11 Cr and net profit ₹3.33 Cr.
Company filings, standalone accounts; latest reported quarter Mar 2026
| Mar 2023 | Sep 2023 | Mar 2024 | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Sales | 7.43 | 10.83 | 12.11 | 12.41 | 10.33 | 10.47 | 12.62 |
| Expenses | 7.90 | 9.96 | 8.43 | 7.88 | 10.48 | 8.32 | 9.43 |
| Operating Profit | −0.51 | 0.84 | 3.64 | 4.48 | −0.22 | 2.12 | 3.14 |
| OPM % | −6.7% | 7.7% | 30.2% | 36.2% | −2.0% | 20.3% | 25.0% |
| Other Income | 3.05 | 2.60 | 1.60 | 0.06 | 4.18 | 0.89 | 1.95 |
| Interest | 3.16 | 1.45 | 1.44 | 1.01 | 0.69 | 0.62 | 0.54 |
| Depreciation | 1.48 | 1.46 | 1.44 | 1.57 | 1.36 | 1.47 | 1.50 |
| Profit before tax | −2.09 | 0.50 | 2.33 | 1.93 | 1.91 | 0.91 | 3.02 |
| Tax % | 0.0% | 17.6% | 17.1% | 16.5% | 14.6% | 15.2% | 15.5% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.80 | 0.51 | 0.00 |
| Net Profit | −2.11 | 0.43 | 1.94 | 1.63 | 1.66 | 0.79 | 2.55 |
| EPS (Rs) | −0.89 | 0.17 | 0.81 | 0.68 | 0.70 | 0.32 | 1.08 |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Sales | 27.79 | 27.35 | 40.85 | 39.90 | 19.00 | 22.94 | 22.76 | 23.11 |
| Expenses | 18.06 | 18.38 | 30.70 | 31.13 | 18.56 | 18.39 | 18.35 | 17.76 |
| Operating Profit | 9.62 | 8.85 | 10.00 | 8.60 | 0.36 | 4.47 | 4.30 | 5.25 |
| OPM % | 34.8% | 32.5% | 24.6% | 21.7% | 1.9% | 19.6% | 19.0% | 22.8% |
| Other Income | 0.05 | 0.01 | 0.00 | 0.12 | 3.09 | 4.20 | 4.24 | 2.85 |
| Interest | 5.73 | 4.88 | 3.24 | 2.95 | 3.08 | 2.90 | 1.71 | 1.17 |
| Depreciation | 2.53 | 2.55 | 2.62 | 2.91 | 2.92 | 2.91 | 2.94 | 2.96 |
| Profit before tax | 1.35 | 1.37 | 4.10 | 2.83 | −2.56 | 2.83 | 3.86 | 3.94 |
| Tax % | 0.0% | 0.0% | 0.0% | 16.5% | 0.0% | 17.2% | 15.5% | 15.7% |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | −0.02 | 0.94 | 0.51 |
| Net Profit | 1.37 | 1.39 | 4.12 | 2.36 | −2.58 | 2.37 | 3.28 | 3.33 |
| EPS (Rs) | 0.75 | 0.76 | 2.27 | 1.00 | −1.09 | 1.00 | 1.39 | 1.42 |
| Dividend payout % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Equity Capital | 17.18 | 17.94 | 18.02 | 23.31 | 23.30 | 23.29 | 23.31 | 23.34 |
| Reserves | −1.80 | 6.31 | 11.29 | 73.44 | 70.80 | 73.08 | 76.38 | 80.07 |
| Borrowings | 33.05 | 30.97 | 27.91 | 28.16 | 29.12 | 20.34 | 12.58 | 8.22 |
| Other Liabilities | 5.74 | 4.95 | 8.00 | 4.31 | 4.90 | 4.76 | 3.89 | 4.31 |
| Total Liabilities | 54.17 | 60.17 | 65.22 | 129 | 128 | 121 | 116 | 116 |
| Fixed Assets | 46.47 | 44.24 | 49.62 | 48.52 | 45.59 | 42.84 | 40.89 | 41.57 |
| CWIP | 0.09 | 0.00 | 0.00 | 0.00 | 0.06 | 0.46 | 0.89 | 0.00 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Assets | 7.61 | 15.93 | 15.60 | 80.70 | 82.47 | 78.17 | 74.38 | 74.37 |
| Inventories | 0.00 | 1.01 | 1.01 | 1.01 | 0.00 | 0.00 | 0.00 | 0.00 |
| Trade receivables | 3.01 | 7.01 | 7.01 | 8.01 | 7.01 | 5.01 | 5.01 | 7.01 |
| Cash & equivalents | 0.99 | 3.99 | 2.99 | 0.99 | 2.99 | 1.99 | 2.99 | 3.99 |
| Total Assets | 54.17 | 60.17 | 65.22 | 129 | 128 | 121 | 116 | 116 |
| Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|
| Cash from operating activity | −0.97 | 14.52 | −62.72 | 1.02 | 7.20 | 9.21 | 7.81 |
| Cash from investing activity | −0.25 | −7.99 | −1.88 | −0.08 | −0.64 | −1.37 | −2.81 |
| Cash from financing activity | 4.17 | −7.98 | 62.72 | 1.06 | −7.63 | −7.22 | −3.25 |
| Net cash flow | 2.97 | −1.45 | −1.87 | 2.00 | −1.09 | 0.62 | 1.74 |
| Capex | 0.25 | 8.00 | 1.88 | 0.08 | 0.68 | 1.39 | 2.83 |
| Free cash flow | −1.19 | 6.50 | −64.24 | 0.93 | 6.53 | 7.79 | 4.95 |
| CFO / OP % | −8.0% | 148.0% | −725.0% | 289.0% | 172.0% | 229.0% | 160.0% |
| Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|
| Debtor days | 46 | 90 | 66 | 72 | 132 | 77 | 76 | 111 |
| Inventory days | 52 | 68 | 31 | 36 | 58 | 50 | 60 | 50 |
| Days payable | 298 | 248 | 242 | 102 | 366 | 265 | 131 | 196 |
| Cash conversion cycle | −201 | −91 | −146 | 5 | −177 | −139 | 3 | −36 |
| Working capital days | −92 | 21 | −37 | −33 | −125 | −122 | 4 | 105 |
| ROCE % | — | 12.2% | 13.1% | 6.4% | 0.4% | 4.8% | 4.1% | 4.0% |
For the Mar 2026 quarter, Aashka Hospitals reported sales of ₹12.62 Cr, up 22.2% year on year and net profit of ₹2.55 Cr, up 53.6% year on year. The operating margin was 25.0%.
Aashka Hospitals' sales for the year to Mar 2026 were ₹23.11 Cr.
Net profit for the year to Mar 2026 was ₹3.33 Cr. Earnings per share over the same trailing period were ₹1.42.
Aashka Hospitals reported borrowings of ₹8.22 Cr at Mar 2026, against cash and equivalents of ₹3.99 Cr.
Cash from operations was ₹7.81 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹4.95 Cr.